| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/29/1999 | CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | CA2306980A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | CA2306870A1 Bicyclic kinase inhibitors |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306233A1 Potentiation of pharmaceuticals |
| 04/28/1999 | EP0911413A2 Minimal adenovirus-based gene therapy vector |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0911321A2 Compounds for the treatment of osteoporosis |
| 04/28/1999 | EP0911319A1 Malonic acid based matrix metalloproteinase inhibitors |
| 04/28/1999 | EP0911311A1 Preparation of lycopene metabolites |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910583A1 Thrombin inhibitors |
| 04/28/1999 | EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 04/28/1999 | EP0910566A1 Heterocyclic compounds and their preparation and use |
| 04/28/1999 | EP0910565A1 Amide derivatives as selective neuropeptide y receptor antagonists |
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910563A1 Integrin receptor antagonists |
| 04/28/1999 | EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 04/28/1999 | EP0910398A1 Method of stimulating cilia |
| 04/28/1999 | EP0910385A1 Sensitization of cells to radiation and chemotherapy |
| 04/28/1999 | EP0910384A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
| 04/28/1999 | EP0910372A1 Pharmaceutical compositions containing mesembrine and related compounds |
| 04/28/1999 | EP0910351A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0775150B1 Endotoxin reduction or removal process |
| 04/28/1999 | EP0679092B1 Cytokine restraining agents |
| 04/28/1999 | EP0655907B1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 04/28/1999 | EP0650361B1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 04/28/1999 | EP0625991B1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 04/28/1999 | EP0494268B2 Method for inhibiting growth of stem cells |
| 04/28/1999 | CN1215431A Genomic nucleic acids, cDNA and mDNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215400A Piperazine and piperidine compounds |
| 04/28/1999 | CN1215399A Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 04/28/1999 | CN1215392A Histamine H3 receptor ligands |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215335A Method fo treating heart failure with endothelin antagonists |
| 04/28/1999 | CN1215333A Use of derivativ |
| 04/28/1999 | CN1214937A Traditional Chinese medicine for reinforcing kidney and enhancing fitness of female old aged people |
| 04/28/1999 | CN1214936A Traditional Chinese medicine preparation for reinforcing kidney and enhancing fitness of femal middle-aged perpon |
| 04/28/1999 | CN1214915A Traditional Chinese medicine preparation for invigrating brain tonifying and enhancing fitness of female teen-agers |
| 04/28/1999 | CN1214914A Traditional Chinese medicine preparation for reinforcing the kidney and enhancing fitness of male middle-aged person |
| 04/28/1999 | CN1214913A Traditional Chinese medicine preparation for invigorating brain and enhancing fitness of teen-agers |
| 04/28/1999 | CN1214911A Traditional Chinese medicine preparation for reinforcing the kidney and enhancing fitness of old age people |
| 04/27/1999 | US5898031 Oligoribonucleotides for cleaving RNA |
| 04/27/1999 | US5897891 Consists of a zinc compound, a mono-carboxylic amino acid, and lesser amount of copper compound; pleasant flavor |
| 04/27/1999 | CA2163778C Indole derivatives as steroid 5a-reductase inhibitors |
| 04/27/1999 | CA2096036C Method for stimulating intracellular synthesis of glutathione using esters of l-2-oxothiazolidine-4-carboxylate |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/22/1999 | WO1999019495A1 Phosphodiesterase 8a |
| 04/22/1999 | WO1999019494A1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 04/22/1999 | WO1999019486A1 Cell division regulators |
| 04/22/1999 | WO1999019480A2 Human receptor proteins; related reagents and methods |
| 04/22/1999 | WO1999019478A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 04/22/1999 | WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 04/22/1999 | WO1999019342A1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/22/1999 | WO1999019339A1 53 human secreted proteins |
| 04/22/1999 | WO1999019338A1 Inhibitors of nucleoside metabolism |
| 04/22/1999 | WO1999019332A1 Combined generation of phosphinic acid derivatives |
| 04/22/1999 | WO1999019325A1 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 04/22/1999 | WO1999019323A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use |
| 04/22/1999 | WO1999019300A1 Prostaglandin agonists and their use to treat bone disorders |
| 04/22/1999 | WO1999019299A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
| 04/22/1999 | WO1999019298A1 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS |
| 04/22/1999 | WO1999019296A1 Aminobutanoic acid derivatives |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018967A1 Analgesic compositions |
| 04/22/1999 | WO1999018962A1 Pharmaceutically active compound and methods of use |
| 04/22/1999 | WO1999018952A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 04/22/1999 | WO1999018951A1 Inhibitors of farnesyl protein transferase |
| 04/22/1999 | WO1999018949A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | WO1999018942A1 Use of csaidtm compounds for the management of uterine contractions |
| 04/22/1999 | WO1999018941A2 Ih-MODULATORS |
| 04/22/1999 | WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | WO1999018793A1 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 04/22/1999 | WO1999013717B1 A delivery of arginine to cause beneficial effects |
| 04/22/1999 | WO1999011624B1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 04/22/1999 | WO1999006361A3 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 04/22/1999 | WO1999001556A3 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1999001118A3 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 04/22/1999 | WO1998053068A9 Smad7 and uses thereof |
| 04/22/1999 | WO1998050383A8 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 04/22/1999 | WO1998043618A9 Use of cytoskeletal inhibitors for the prevention of restenosis |
| 04/22/1999 | WO1998021221A3 1-thiogalactose derivatives |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | CA2316296A1 Use of csaidtm compounds for the management of uterine contractions |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2307929A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors |